A Study Of Rorschach’s Test In Patients With Autoimmune Diseases And Possible Relation With Opioid And Cannabinoid Systems
Research Article
Abstract views: 103 / PDF downloads: 61
DOI:
https://doi.org/10.58372/2835-6276.1199Keywords:
Rorschach, autoimmune, spiritualityAbstract
ObjectiveThere are few studies examining psychological characteristics in patients with autoimmune disease, while significantly more attention has been given to emotional, personality changes and cognitive profile in cancer disease. A irreversible chronic and pervasive disorder brings many life stresses and affects the patient's ability to cope with them. This study explored the personality characteristics in a sample of patients affected by the most common autoimmune diseases. .
MethodsAfter having informed consent, 40 patients (8 male and 32 female, age; 46 ± standard deviation) with autoimmune disease were included. Information about sociodemographic data and clinical details was collected using the sociodemographic and clinical data sheet from the drawn sample. All participants were administered the Rorschach Test by the psychologist.
ResultsFrom a relationship point of view, all patients approached the test with a collaborative attitude and they often manifested an open interest for the diagnostic material. The Rorschach administration was conducted without any irregularity. Most of patients gave more than 20 answers, 46% of the patients gave a number of detail answers inferior to the normative range, 65% of the test presented a number of human content in the normative range. In 70% of the patients, the index intimate resonance (T.R.I.) index was extra tensive. Our findings show that the patients in our sample perceive themselves as being less competent than others, at some cost to their self-esteem. A large percentage relies on an avoidant style of coping with problems. The spirituality is present in patients with autoimmune disease unlike cancer patients. Its absence tends to compromise the sexual one as well.
ConclusionThese findings suggest that some variables of the Rorschach test could assist with medical treatment of autoimmune disease and the test could be one of the most useful diagnostic tools to explore personality traits and psychological functioning.
References
Ursin H. The Psychology in Psychoneuroendocrinology. Psychoneuroendo-crinology 23: 555-570, 1998.
Lissoni P, Messina G et al.The psychoneuroimmunotherapy of human immune-mediated systemic diseases, including cancer and autoimmune diseases. Mol Oncol Res. 1(1):7-13, 2017.
Rubinow DR. Brain, behaviour and immunity: an interactive system. J Natl Cancer Inst Monogr 10: 79-82, 1990.
Messina G, Lissoni P et al. A psychoncological study of lymphocyte subpopulations in relation to pleasure-related neurobiochemistry and sexual and spiritual profile to Rorschach's test in early or advanced cancer patients J Biol Regul Homeost Agents (4):322-6, 2003
Lissoni P, Messina G et al. Clinical Psychoneuroendocrinoimmunology, Natur, 2012
Mengelkoch S, Gassen J et al. Exploring the links between personality and immune function. Pers Individ Dif. Author manuscript; available in PMC 2023
Benedict R, Amato MP et al. Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues. 19(10):860-90, 2020
Messina G, Lissoni P et al. Psychoimmunological analysis of cancer patients: correlation with the prognosis Curr Aging Sci 5(3):263-72, 2012
Areh I, Verkampt F et al. Critical review of the use of the Rorschach in European courts. Psychiatr Psychol Law. 29(2): 183–205, 2022
Rubinow DR. Brain, behaviour and immunity: an interactive system. J Natl Cancer Inst Monogr 10: 79-82, 1990
Zou W. Regulatory T cells, tumor immunity and immunotherapy. Nat Rev Immunol 6: 295-307, 2006
Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology 134: 8-16, 2011
Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1: 1333-1349, 2009
Katchan V, David P et al. Cannabinoids and autoimmune diseases: A systematic review. Autoimmun Rev 15 (6): 513-28, 2016
Xuan Lian D, Renyu Liu et al. Opioid System Modulates the Immune Function: A Review Transl Perioper Pain Med. 2016; 1(1): 5–13.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 American Journal of Medical and Clinical Research & Reviews
This work is licensed under a Creative Commons Attribution 4.0 International License.